Opinion
Video
The Role for Systematic Biopsy Plus MRI-Targeted Procedures
Author(s):
Focusing on the role of systematic biopsy, the panel provides clinical insights on biopsy practice patterns after encountering suspicious-looking areas on MRI.
Video Player is loading.
Video content above is prompted by the following questions:
- What are some of the key differences between organ-based tracking and probe tracking technologies used in the current fusion-guided platforms? How do these differences impact the procedural workflow or your approach to these procedures?
- How do fusion-guided and MRI-targeted biopsy options compare? What are some of the key differences between MRI/US fusion-guided elastic biopsy and MRI-targeted biopsy?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Data link incontinence severity to post-radical prostatectomy care
Jim Hu, MD, on upgrading of GG1 prostate cancer at radical prostatectomy
Expert discusses differentiating prostate cancer from age-related issues
Howard Goldman, MD, discusses development of the Glean Urodynamics System
Murilo De Almeida Luz, MD, on PSA and ALP changes with enzalutamide/radium-223
Ruben Olivares, MD, discusses remote robot–assisted HIFU for prostate cancer
Strategies to bridge gender disparities in AAS and citations in the oncology literature
Stacy Loeb, MD, MSc, PhD (Hon), discusses the nuances of prostate cancer screening
Selecting Between Receptor Pathway Inhibitors for mHSPC
The Use of Ultra-Low PSA in Specific Patient Profiles
Related Content
